A Multicentre, Observational Study to Evaluate the Real-World Outcomes of Palynziq (Pegvaliase) in Subjects With Phenylketonuria (OPAL)

Grants and Contracts Details

StatusActive
Effective start/end date12/5/2312/5/25

Funding

  • BioMarin Pharma Inc: $2.00